RxDoctor Payments Data

Crystal Divic

Family · Tucson, AZNPI 1215624457

Payments from drug & device makers

$1,403in general payments, 2019–2025

Across 82 payments — averaging $17.11 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Amgen$237
  • AstraZeneca$205
  • AbbVie$131
  • Exact Sciences$102
  • Sumitomo Pharma America, Inc.$88
  • Eisai Inc.$66
  • plus $575 from 16 others

What the payments were for

  • Food & beverage$1,403100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,403 in reported general payments places this provider in the 75th percentile of 4,119 family providers in Arizona.

See all family providers in Arizona

Medicare billing

Part B allowed, 2024
$71,550
Medicare patients
197
Services billed
1,414

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MounjaroTirzepatide65$90,974
EliquisApixaban33$24,935
GemtesaVibegron19$16,812
JardianceEmpagliflozin12$15,557
MyrbetriqMirabegron18$12,368
Donepezil Hcl32$2,058
Duloxetine Hcl68$1,786
PaxlovidNirmatrelvir/Ritonavir17$1,429
Albuterol Sulfate HfaAlbuterol Sulfate39$1,330
Levothyroxine Sodium130$1,071
Methocarbamol42$965
Amlodipine Besylate97$941
Losartan Potassium86$910
Tamsulosin Hcl42$785
Pantoprazole Sodium40$748

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro$61$90,97465 claims
Sumitomo Pharma America, Inc.Gemtesa$88$16,81219 claims
Boehringer IngelheimJardiance$33$15,55712 claims
Astellas Pharma US IncMyrbetriq$40$12,36818 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 4,119 family providers in Arizona.

Other family in Tucson

See the full list for Arizona

Where these figures come from

Is this you, or does something look wrong? →